Metastatic spread from breast cancer is the second-leading cause of brain metastasis (BM). Preclinical and clinical evidence suggests that abemaciclib, a selective CDK4/6 inhibitor, has the ability to cross the blood-brain barrier. To assess the intracranial objective response rate (iORR) of abemaciclib in patients with breast cancer with CNS involvement, Tolaney and colleagues performed a phase 2 clinical trial of abemaciclib with or without endocrine therap. or trastuzumab. Although this study did not meet its primary endpoint, abemaciclib was associated with an intracranial clinical benefit rate of 24% in patients with HR+, HER2- disease with secondary BM. Pharmacologically relevant evidence of abemaciclib was observed in BM and CSF from treated patients. Furthermore, in patients with leptomeningeal metastases, abemaciclib treatment led to disease control and improved OS longer than expected, based on historical controls. These results suggest the need for further study of abemaciclib in breast cancer with CNS metastasis, especially...
Skip Nav Destination
Article navigation
15 October 2020
Highlights|
October 15 2020
Selected Articles from This Issue
Online ISSN: 1557-3265
Print ISSN: 1078-0432
©2020 American Association for Cancer Research.
2020
American Association for Cancer Research.
Clin Cancer Res (2020) 26 (20): 5269.
Related Content
This is a related article to:
Clinical Evaluation of (4S)-4-(3-[18F]Fluoropropyl)-L-glutamate (18F-FSPG) for PET/CT Imaging in Patients with Newly Diagnosed and Recurrent Prostate Cancer
This is a related article to:
Diffusion Histology Imaging Combining Diffusion Basis Spectrum Imaging (DBSI) and Machine Learning Improves Detection and Classification of Glioblastoma Pathology
This is a related article to:
Evolution of Genomic and T-cell Repertoire Heterogeneity of Malignant Pleural Mesothelioma Under Dasatinib Treatment
This is a related article to:
A Phase II Study of Abemaciclib in Patients with Brain Metastases Secondary to Hormone Receptor–Positive Breast Cancer
- Views Icon Views
- Share Icon Share
-
Tools Icon
Tools
- Search Site
-
Article Versions Icon
Versions
- Version of Record October 15 2020
Citation
Selected Articles from This Issue. Clin Cancer Res 15 October 2020; 26 (20): 5269. https://doi.org/10.1158/1078-0432.5269.26.20
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Pay-Per-View 24-Hour Access
$50.00
312
Views
Citing articles via
Advertisement